Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in Germany

Citations of this article
Mendeley users who have this article in their library.


Objectives. This summary evaluates the outcomes of orthotopic liver transplantation (OLT) of HIV-positive patients in Germany. Methods. Retrospective chart analysis of HIV-positive patients, who had been liver-transplanted in Germany between July 1997 and July 2011. Results. 38 transplantations were performed in 32 patients at 9 German transplant centres. The reasons for OLT were end-stage liver disease (ESLD) and/or liver failure due to hepatitis C (HCV) (n=19), hepatitis B (HBV) (n=10), multiple viral infections of the liver (n=2) and Budd-Chiari-Syndrome. In July 2011 19/32 (60%) of the transplanted patients were still alive with a median survival of 61 months (IQR (interquartile range): 41-86 months). 6 patients had died in the early post-transplantation period from septicaemia (n=4), primary graft dysfunction (n=1), and intrathoracal hemorrhage (n=1). Later on 7 patients had died from septicaemia (n=2), delayed graft failure (n=2), recurrent HCC (n=2), and renal failure (n=1). Recurrent HBV infection was efficiently prevented in 11/12 patients; HCV reinfection occurred in all patients and contributed considerably to the overall mortality. Conclusions. Overall OLT is a feasible approach in HIV-infected patients with acceptable survival rates in Germany. Reinfection with HCV still remains a major clinical challenge in HIV/HCV coinfection after OLT. © 2012 E. Anadol et al.




Anadol, E., Beckebaum, S., Radecke, K., Paul, A., Zoufaly, A., Bickel, M., … Spengler, U. (2012). Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in Germany. AIDS Research and Treatment, 2012. https://doi.org/10.1155/2012/197501

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free